Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
WT1 encodes a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. Additionally we are shipping WT1 Kits (11) and WT1 Proteins (9) and many more products for this protein.
Showing 10 out of 222 products:
Human Monoclonal WT1 Primary Antibody for WB - ABIN394194
Rocquain, Carbuccia, Trouplin, Raynaud, Murati, Nezri, Tadrist, Olschwang, Vey, Birnbaum, Gelsi-Boyer, Mozziconacci: Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias. in BMC cancer 2010
Show all 5 references for ABIN394194
Human Polyclonal WT1 Primary Antibody for FACS, IF - ABIN655904
Sitaram, Degerman, Ljungberg, Andersson, Oji, Sugiyama, Roos, Li: Wilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways. in British journal of cancer 2010
Show all 5 references for ABIN655904
Human Monoclonal WT1 Primary Antibody for IHC, IHC (fro) - ABIN258719
Rauscher, Morris, Fredericks, Lopez-Guisa, Balakrishnan, Jost, Herlyn, Rodeck: Characterization of monoclonal antibodies directed to the amino-terminus of the WT1, Wilms' tumor suppressor protein. in Hybridoma 1998
Show all 4 references for ABIN258719
Human Polyclonal WT1 Primary Antibody for EIA, IF - ABIN955586
Dohi, Ohno, Ohno, Kyo, Soma, Sugiyama, Inoue: WT1 expression correlates with angiogenesis in endometrial cancer tissue. in Anticancer research 2010
Show all 4 references for ABIN955586
Mouse (Murine) Polyclonal WT1 Primary Antibody for IHC, WB - ABIN3021698
Sharma, Bowman, Madden, Rauscher, Sukumar: RNA editing in the Wilms' tumor susceptibility gene, WT1. in Genes & development 1994
Human Polyclonal WT1 Primary Antibody for ELISA, WB - ABIN185674
Rao, Pham, Imam, MacLean, Murali, Furuta, Sinha-Hikim, Wilkinson: Tissue-specific RNAi reveals that WT1 expression in nurse cells controls germ cell survival and spermatogenesis. in Genes & development 2006
Chicken Polyclonal WT1 Primary Antibody for IHC, WB - ABIN2780340
Ruteshouser, Robinson, Huff: Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors. in Genes, chromosomes & cancer 2008
WT1 interference with Wnt (show WNT2 Antibodies) signaling represents an important mode of its action relevant to the suppression of tumor growth and guidance of development.
WT1 gene mutations are a predictor indicator of a poor prognosis factor in CN-AML (show RUNX1 Antibodies) patients.
Patients with Wilms tumor 1 mutations did not show significant differences in clinical outcomes, including relapse or death during follow-up, compared with those without Wilms tumor 1 mutation.
The individuals carrying variant G alleles of WT1 rs16754 showed a relatively low prevalence of myeloproliferative neoplasm, compared with those carrying A alleles of Wilms tumor 1 rs16754; the G allele for Wilms tumor 1 rs16754 might reduce the risk of developing myeloproliferative neoplasm.
Vimentin (show VIM Antibodies), Nestin (show NES Antibodies) and WT1. Sox2 (show SOX2 Antibodies) was expressed by the stem/progenitor cells of the ventricular zone, whereas the postmitotic neurons of the cortical plate were immunostained by PAX2 (show PAX2 Antibodies) and NSE (show ENO2 Antibodies).
WT1 variant is associated with response to chemotherapy in breast cancer.
WT1 SNPs play no role in regulating the relationship between IFN-beta (show IFNB1 Antibodies) and serum 25-hydroxyvitamin D in MS patients.
WT1 gene expression is associated with a poor outcome for patients showing non-MYCN (show MYCN Antibodies)-amplified neuroblastoma (show ARHGEF16 Antibodies) tumors.
High WT1 gene expression is associated with Acute Myeloid Leukemia (show BCL11A Antibodies).
HuR (show ELAVL1 Antibodies) binds to the pyrimidine-rich sequence and antagonize its effect in regulating WT1 +/-KTS isoforms.
High WT1 expression is associated with colorectal cancer.
Sodium butyrate-induced hyperacetylation up-regulates WT1 expression in porcine kidney fibroblasts, suggesting the involvement of histone acetylation in the transcriptional modulation of WT1 in porcine kidney cells.
Results indicate that WT1 plays important roles in the development of porcine preimplantation embryos, but not in oocyte maturation.
WT1 is expressed in porcine fetal fibroblasts, but the levels of expression were much lower compared to porcine primary kidney fibroblasts and swine testis, and WT1 is essential for the maintenance of development and survival of porcine fetal fibroblasts
To test the tumorigenic potential of different cell types in the developing kidney, we used kidney progenitor-specific Cre recombinase alleles to introduce Wt1 and Ctnnb1 mutations, two alterations observed in Wilms tumor, into embryonic mouse kidney, with and without biallelic Igf2 expression, another alteration that is observed in a majority of tumors
miR (show MLXIP Antibodies)-125a is a regulatory molecule that suppresses WT1 expression via a direct interaction with the 3'UTR (show UTS2R Antibodies) of WT1 mRNA and miR (show MLXIP Antibodies)-125a knockout mice induce myeloproliferative disease (MPD (show MVD Antibodies)) and urogenital abnormalities
The analysis presented here demonstrates that WT1 regulates a broad set of genes, and almost 50% of the top 200 podocyte-specific genes-as defined in the GUDMAP gene expression atlas-were bound by WT1.
During normal heart development, spatio-temporal differences in contribution of WT-1 and Tcf21 (show TCF21 Antibodies)-LacZ (show GLB1 Antibodies) + cells to right versus left ventricular myocardium occur parallel to myocardial thickening.
Wt1 is essential for normal development at all kidney developmental stages under study.
Wt1 expression levels in podocytes regulate Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) signaling through modulating the endocytic fate of LRP6 (show LRP6 Antibodies), and this indicates a potential target for the therapy of CKD.
The results suggest a possible role for Wt1 in cardiac vessel formation in development and disease.
Conditional beta-catenin (show CTNNB1 Antibodies) loss phenocopies the Wt1 mutant diaphragm defect, while constitutive activation of beta-catenin (show CTNNB1 Antibodies) on the Wt1 mutant background is sufficient to close the diaphragm defect
WT1 modulates receptor tyrosine kinase (show ERBB3 Antibodies) signaling in nephron progenitor cell by directing the expression of Gas1 (show GAS1 Antibodies).
WT1 can modulate LHbeta (show LHB Antibodies) transcription with differential roles for the two WT1 variants
While wt1a has a more fundamental and early role in pronephros development and is essential for the formation of glomerular structures, wt1b functions at later stages of nephrogenesis.
This gene encodes a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilm's tumors. This gene exhibits complex tissue-specific and polymorphic imprinting pattern, with biallelic, and monoallelic expression from the maternal and paternal alleles in different tissues. Multiple transcript variants have been described. In several variants, there is evidence for the use of a non-AUG (CUG) translation initiation site upstream of and in-frame with the first AUG. Authors of PMID:7926762 also provide evidence that WT1 mRNA undergoes RNA editing in human and rat, and that this process is tissue-restricted and developmentally regulated.
Wilms tumor 1
, Wilms tumor protein homolog A
, Wilms tumor protein homolog
, Wilms tumor protein
, amino-terminal domain of EWS
, last three zinc fingers of the DNA-binding domain of WT1
, Wilm's tumor suppressor
, Wilms tumor protein homolog B
, Chick Wilm's tumour protein
, Wilms tumor suppressor protein 1b